Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Hospitals, ambulatory care centers hired 34K workers last month

U.S. healthcare added almost 36,000 jobs in January, with most of the hiring being done by ambulatory health providers (around 23,000 new jobs) and hospitals (10,000).

Thumbnail

60 health systems sign Epic’s letter against interoperability rule

An HHS rule that would enable patients to have free access to their medical records through third-party digital apps is facing a tough battle, with one of the biggest EMR vendor companies, Epic Systems, leading the opposition.

Thumbnail

E-cigarette rules go into effect

New rules about e-cigarettes went into effect Feb. 6, with a partial ban on some flavored products in the U.S. market.

Thumbnail

CMS wants patients to know the cost of Part D drugs in real time in proposed rule

CMS has issued a proposed rule and Advance Notice affecting Medicare Advantages and Medicare Part D prescription drug plans.

Thumbnail

Top 10 biggest health insurance companies

The top 10 largest insurers collectively wrote 51.8% of all healthcare premiums in the U.S. market in 2018.

Thumbnail

Trump asks for bill to lower drug prices in State of the Union address

President Donald Trump gave his annual State of the Union address on Feb. 4, calling on Congress to take on sky-high prescription drug prices.

In Iowa caucuses, healthcare issue takes center stage

Healthcare was top of mind among Iowa caucus-goers as the start of the 2020 election kicked off in the state on Feb. 3. About 60% of Democrats at the Iowa caucuses said they support eliminating private health insurance and moving to a single-payer healthcare system.

Thumbnail

Coronavirus is deadly and expensive

The novel coronavirus, which originated in Wuhan, China, has become the world’s most expensive epidemic, according to data from Learnbonds.com. In fact, the virus, which has been compared to SARS and MERS, is expected to cost China about 2% of its GDP during the first quarter of 2020, or $62 billion.

 

Around the web

The FTC alleges that pharmacy benefit managers have set up a system where they get rich, while patients are forced to pay rising insulin costs. The agency also called out drug manufacturers such as Eli Lilly, Sanofi and Novo Nordisk, saying their own actions have raised serious concerns.

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

Trimed Popup
Trimed Popup